Victor Yu

Victor Yu

Auto-generated profile, based on publicly available information

Victor Yu

Department of Urology Royal Prince Alfred Hospital Camperdown New South Wales Australia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in The Prostate
Verified
Journal Article
Closed access
VYVictor Yu
Victor Yu
PTPatrick‐Julien Treacy
Patrick‐Julien Treacy
RTRuban Thanigasalam
Ruban Thanigasalam
NANariman Ahmadi
Nariman Ahmadi
NDNorbert Doeuk
Norbert Doeuk
SLScott Leslie
Scott Leslie

14 January 2025 in BJU International
Verified
Journal Article
Closed access
VYVictor Yu
Victor Yu
SLSarah Lorger
Sarah Lorger
MBMark Broe
Mark Broe
RTRuban Thanigasalam
Ruban Thanigasalam
SLScott Leslie
Scott Leslie
GMGeorge McClintock
George McClintock

7 April 2025 in Research Square
Verified
Preprint
Open access
PDF file
VYVictor Yu
Victor Yu
PTPatrick Treacy
Patrick Treacy
RTRuban Thanigasalam
Ruban Thanigasalam
NANariman Ahmadi
Nariman Ahmadi
NDNorbert Doeuk
Norbert Doeuk
SLScott Leslie
Scott Leslie
Background: Curative surgery for prostate cancer is uncommonly offered to patients aged ≥75, balancing functional outcomes against survival benefit. The increased adoption of robotic-assisted radical prostatectomy (RARP) and improved overall life expectancy challenges this paradigm. The objective of this study was to compare functional outcomes between elderly and younger patients following RARP. Methods: Retrospective review of prospective multicentre database including all RARP patients between October 2016 to December 2023. Patients were divided into cohorts based on age; elderly (≥75 years) and younger (<75 years). Outcomes included baseline demographics (body mass index [BMI], American Society of Anaesthesiologists [ASA] classification, prostate specific antigen [PSA], Gleason score), surgical (technique, complications, length of stay), pathological (histopathology, margins, PSA) and functional (incontinence, International Prostate Symptom Score [IPSS], International Index of Erectile Function [IIEF-5], Expanded Prostate Index Composite [EPIC]) outcomes. The primary endpoint was continence at 1-year (number of pads/day). Chi-squared and t-tests were used and p-values <0.05 considered statistically significant. Results: A total of 397 patients were included (<75;n=332, ≥75;n=65). No statistically significant differences were detected in continence in ≥75 (<75; 0.73 [0.59-0.87], ≥75;0.66 [0.37-0.95] mean pads/24hr, p=0.8), despite significantly lower nerve preservation and bladder-neck spare rates (<75;37.3%, ≥75;21.5%). IIEF-5 scores were worse in the ≥75 group (1.60±1.17 vs 5.73±6.93 p<0.001), however there were no significant differences in IPSS. Patient in the elderly cohort had more severe disease (67.7% T3, ≥75 vs 47.3%, <75, p<0.05) Rates of positive surgical margins (28.3% vs 30.8% [≥75]) and PSA recurrence (25% vs 23% [≥75]) were similar. Complication rates were low in both groups with no significant differences (3% vs 6.6% [≥75]) and were of lower severity in the ≥75 group. Conclusion: RARP in carefully selected elderly patients does not increase risk of urinary incontinence and should not be disregarded in an aging population with higher overall life expectancy.

23 February 2026 in Journal of Liver Transplantation
Verified
Journal Article
Open access
VYVictor Yu
Victor Yu
DPDmitry Polikarpov
Dmitry Polikarpov
APAleksandra Polikarpova
Aleksandra Polikarpova
MCMichael Crawford
Michael Crawford
CPCarlo Pulitano
Carlo Pulitano

1 July 2026 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
VYVictor Yu
Victor Yu
DGDamien Gibson
Damien Gibson
JCJuliette Cotte
Juliette Cotte
AAAmer Amin
Amer Amin
LCLewis Chan
Lewis Chan
SLScott Leslie
Scott Leslie
Aim: The Robosling technique is a novel autologous fascial sling which supports the urethrovesical anastomosis in robotic radical prostatectomy (RARP) and has shown promise in improving early continence. Although curative surgery for prostate cancer is uncommonly offered to elderly patients aged ≥ 75, increase in active surveillance and overall life expectancy challenges this paradigm, though continence remains a challenge in this cohort. We sought to investigate the role of the Robosling technique in elderly patients to promote early return of continence. Methods: Our prospective RARP database (2016– 2023) was analysed, recording demographic, surgical, pathological and functional outcomes. The primary endpoint was defined as pad-free continence, 1-year post-operatively. Patients aged ≥ 75 undergoing RARP with or without Robosling were compared using Chi-square/Fisher-exact and t-tests with p< 0.05 considered significant. Multinomial logistic regression was performed to account for confounders. Results: 62 patients were included in the analysis (Robosling n=24). No significant differences were detected in surgical or pathological outcomes. Robosling was associated with improved pad-free continence rates from 6-months post-operatively (62.5% vs 30.0%, p=0.018) and sustained at 1-year (79.2% vs 30.0%, p< 0.01). Mean pad-use was lower in the Robosling cohort at all time points (0.21 vs 1.0 pads at 1-year, p< 0.05). On multivariate analysis, Robosling remained independently associated with improved pad-free continence (OR 0.11, 95% CI 0.03– 0.37, p< 0.001). Conclusion: The Robosling technique is associated with significantly improved early and sustained pad-free continence rates in the elderly population in this single-surgeon study. While patient selection remains paramount, this intraoperative technique may mitigate a key quality-of-life concern in this cohort.

Verified
Journal Article
Open access
PDF file
VYVictor Yu
Victor Yu
LCLi Si Chong
Li Si Chong
SKSascha Karunaratne
Sascha Karunaratne
Daniel SteffensDaniel Steffens
Daniel Steffens
KBKilian Brown
Kilian Brown
NJNicola Jeffery
Nicola Jeffery
Background/Objectives: Crohn’s disease (CD) is traditionally considered a relative contraindication to ileal conduit (IC) urinary diversion, yet published evidence remains limited. This study evaluated urological complication rates and short-term outcomes of CD patients undergoing IC formation during pelvic exenteration (PE) for advanced pelvic malignancy and benign fistulae. Methods: An institutional prospective PE database (2008–2024) was analysed comparing patients with or without CD. The primary endpoint included urological complications (ureteroileal anastomotic leak and stricture, conduit leak, and stenosis) and need for re-intervention (nephrostomy, antegrade stents, revision surgery). Statistical analysis included Fisher-exact and Mann–Whitney-U tests (p ≤ 0.05), with multivariate regression controlling for age, disease factors, and operative complexity. Results: Among 441 patients who underwent IC formation, 12 had CD. The CD cohort was younger and more commonly had recurrent rectal cancers (67.0% vs. 34.0%; p = 0.02), requiring more complex resections including sacrectomy (83.0% vs. 52.0%; p = 0.04) and experiencing greater blood loss (5000 vs. 2400 mL; p = 0.04). CD patients had higher overall urological complication rates (41.7% vs. 13.3%; p = 0.017) and re-intervention was more frequent, including percutaneous nephrostomy (41.7% vs. 11.2%; p = 0.009) and revision surgery (25.0% vs. 4.7%; p = 0.02). On multivariate analysis, CD remained independently associated with need for re-intervention (odds ratio [OR] = 4.48, 95% confidence interval [CI] = 1.35–14.89; p = 0.014). Conclusions: CD does not appear to preclude IC formation in PE surgery. Despite potentially higher urological complication risk in a complex surgical cohort, the results of this study highlight its feasibility in selected patients managed in a high-volume centre.